MedTech marketing for a B2B market where physicians decide — and procurement follows.
MedTech isn't sold in the commercial. It's decided in studies, at congresses, in operating rooms and in procurement committees. We build brand work that builds HCP trust — and delivers procurement argumentation in parallel.
Experience with MedTech manufacturers and diagnostics brands across DACH. References on request.
Book a conversationA MedTech brand is decided in the congress hall — not in the LinkedIn ad.
Studies, KOLs and peer reviews are the brand asset class in MedTech. Understanding this builds long-term user loyalty. Ignoring it means buying in via price.
Evidence beats storytelling.
Studies, numbers, references aren't dry extras — they're the brand asset. HCPs read differently than consumers.
KOL building is long-term.
Key opinion leaders emerge over years, not campaigns. Marketing has to orchestrate that build — studies, talks, publications.
MDR and pharma advertising law set the limit.
Medical Device Regulation and pharma advertising law. What isn't regulatory-clean can't run. Compliance is a co-designer, not a correction.
Procurement decides differently than HCPs.
Physicians decide on outcome, procurement on total cost of ownership. Both need their own argumentation — one message for both rarely works.
Branding for MedTech
Brand architecture for manufacturers, product lines and indication brands. Evidence-based, regulatory-clean.
Longform Entertainment / HCP Education
Documentary formats, surgery films, KOL interviews. Material that works in continuing education.
Congress & sales enablement
Congress presence, pitch decks, study communication — material that works in front of HCPs and procurement.
AISEO / GEO for indication search
Presence when AI assistants are asked about procedures, devices, providers — regulatory-clean.
Let’s talk.
Let’s find out where your real lever is. One conversation. An honest assessment. Virtual or in person.
Or write us directly at hello@baconbold.com